(CAG) ConAgra Foods - Ratings and Ratios
Frozen Meals, Shelf-Stable Entrees, Snacks, Baking Mixes, Whipped Toppings
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 10.04% |
| Yield on Cost 5y | 6.09% |
| Yield CAGR 5y | 5.98% |
| Payout Consistency | 94.2% |
| Payout Ratio | 2.0% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 22.9% |
| Value at Risk 5%th | 37.0% |
| Relative Tail Risk | -1.63% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -1.61 |
| Alpha | -37.33 |
| CAGR/Max DD | -0.37 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.312 |
| Beta | 0.067 |
| Beta Downside | -0.013 |
| Drawdowns 3y | |
|---|---|
| Max DD | 52.41% |
| Mean DD | 27.33% |
| Median DD | 26.42% |
Description: CAG ConAgra Foods November 04, 2025
Conagra Brands, Inc. (NYSE:CAG) is a U.S.–based consumer packaged goods company that sells a broad portfolio of shelf-stable, refrigerated, and frozen foods across four segments: Grocery & Snacks, Refrigerated & Frozen, International, and Foodservice. Its brands-including Birds Eye, Marie Callender’s, Duncan Hines, Healthy Choice, Slim Jim, Reddi-Wip, Angies, and BOOMCHICKAPOP-are distributed through grocery retailers, club stores, e-commerce platforms, and foodservice outlets, with the International segment extending these offerings outside the United States.
Key performance indicators to watch include the 12-month trailing same-store sales growth in the Grocery & Snacks segment (historically 2-4% YoY) and the contribution margin expansion from the Refrigerated & Frozen segment, which has benefited from higher pricing power amid rising commodity costs. Macro drivers such as U.S. consumer discretionary spending trends, inflation-adjusted food price indices, and the shift toward “convenient at-home” meals continue to shape demand, while the ongoing supply-chain bottlenecks in cold-storage logistics present both risk and upside for margin improvement.
For a deeper, data-driven assessment of Conagra’s valuation and risk profile, you may find the analytics on ValueRay worth exploring.
Piotroski VR‑10 (Strict, 0-10) 1.5
| Net Income (-98.0m TTM) > 0 and > 6% of Revenue (6% = 674.1m TTM) |
| FCFTA 0.04 (>2.0%) and ΔFCFTA -2.77pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -3.50% (prev -11.35%; Δ 7.85pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.06 (>3.0%) and CFO 1.27b > Net Income -98.0m (YES >=105%, WARN >=100%) |
| Net Debt (7.58b) to EBITDA (901.2m) ratio: 8.41 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.89 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (478.8m) change vs 12m ago -0.10% (target <= -2.0% for YES) |
| Gross Margin 24.54% (prev 27.24%; Δ -2.71pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 55.40% (prev 56.75%; Δ -1.36pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 1.29 (EBITDA TTM 901.2m / Interest Expense TTM 398.0m) >= 6 (WARN >= 3) |
Altman Z'' 1.84
| (A) -0.02 = (Total Current Assets 3.23b - Total Current Liabilities 3.62b) / Total Assets 19.54b |
| (B) 0.30 = Retained Earnings (Balance) 5.92b / Total Assets 19.54b |
| (C) 0.03 = EBIT TTM 515.3m / Avg Total Assets 20.28b |
| (D) 0.77 = Book Value of Equity 8.86b / Total Liabilities 11.45b |
| Total Rating: 1.84 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 44.42
| 1. Piotroski 1.50pt |
| 2. FCF Yield 5.54% |
| 3. FCF Margin 7.80% |
| 4. Debt/Equity 0.94 |
| 5. Debt/Ebitda 8.41 |
| 6. ROIC - WACC (= -0.76)% |
| 7. RoE -1.13% |
| 8. Rev. Trend -35.33% |
| 9. EPS Trend -51.60% |
What is the price of CAG shares?
Over the past week, the price has changed by +2.65%, over one month by -1.36%, over three months by -1.40% and over the past year by -32.35%.
Is CAG a buy, sell or hold?
- Strong Buy: 0
- Buy: 3
- Hold: 16
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the CAG price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 19.1 | 9.6% |
| Analysts Target Price | 19.1 | 9.6% |
| ValueRay Target Price | 16.5 | -5.5% |
CAG Fundamental Data Overview December 28, 2025
P/E Forward = 9.6432
P/S = 0.7341
P/B = 1.0099
P/EG = 12.0743
Beta = -0.016
Revenue TTM = 11.23b USD
EBIT TTM = 515.3m USD
EBITDA TTM = 901.2m USD
Long Term Debt = 6.46b USD (from longTermDebt, last quarter)
Short Term Debt = 1.16b USD (from shortTermDebt, last quarter)
Debt = 7.62b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 7.58b USD (from netDebt column, last quarter)
Enterprise Value = 15.82b USD (8.25b + Debt 7.62b - CCE 46.6m)
Interest Coverage Ratio = 1.29 (Ebit TTM 515.3m / Interest Expense TTM 398.0m)
FCF Yield = 5.54% (FCF TTM 876.4m / Enterprise Value 15.82b)
FCF Margin = 7.80% (FCF TTM 876.4m / Revenue TTM 11.23b)
Net Margin = -0.87% (Net Income TTM -98.0m / Revenue TTM 11.23b)
Gross Margin = 24.54% ((Revenue TTM 11.23b - Cost of Revenue TTM 8.48b) / Revenue TTM)
Gross Margin QoQ = 23.44% (prev 24.33%)
Tobins Q-Ratio = 0.81 (Enterprise Value 15.82b / Total Assets 19.54b)
Interest Expense / Debt = 1.30% (Interest Expense 99.2m / Debt 7.62b)
Taxrate = -1.27% (negative due to tax credits) (8.30m / -655.3m)
NOPAT = 521.8m (EBIT 515.3m * (1 - -1.27%)) [negative tax rate / tax credits]
Current Ratio = 0.89 (Total Current Assets 3.23b / Total Current Liabilities 3.62b)
Debt / Equity = 0.94 (Debt 7.62b / totalStockholderEquity, last quarter 8.09b)
Debt / EBITDA = 8.41 (Net Debt 7.58b / EBITDA 901.2m)
Debt / FCF = 8.65 (Net Debt 7.58b / FCF TTM 876.4m)
Total Stockholder Equity = 8.68b (last 4 quarters mean from totalStockholderEquity)
RoA = -0.50% (Net Income -98.0m / Total Assets 19.54b)
RoE = -1.13% (Net Income TTM -98.0m / Total Stockholder Equity 8.68b)
RoCE = 3.40% (EBIT 515.3m / Capital Employed (Equity 8.68b + L.T.Debt 6.46b))
RoIC = 3.12% (NOPAT 521.8m / Invested Capital 16.71b)
WACC = 3.89% (E(8.25b)/V(15.87b) * Re(6.26%) + D(7.62b)/V(15.87b) * Rd(1.30%) * (1-Tc(-0.01)))
Discount Rate = 6.26% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -100.0 | Cagr: -0.10%
[DCF Debug] Terminal Value 79.18% ; FCFE base≈1.14b ; Y1≈1.21b ; Y5≈1.46b
Fair Price DCF = 53.22 (DCF Value 25.46b / Shares Outstanding 478.4m; 5y FCF grow 7.20% → 3.0% )
EPS Correlation: -51.60 | EPS CAGR: -60.32% | SUE: -4.0 | # QB: 0
Revenue Correlation: -35.33 | Revenue CAGR: 0.59% | SUE: -0.09 | # QB: 0
EPS next Quarter (2026-02-28): EPS=0.40 | Chg30d=-0.024 | Revisions Net=-7 | Analysts=13
EPS current Year (2026-05-31): EPS=1.95 | Chg30d=+0.123 | Revisions Net=-1 | Growth EPS=-19.0% | Growth Revenue=-3.3%
EPS next Year (2027-05-31): EPS=1.82 | Chg30d=-0.053 | Revisions Net=-8 | Growth EPS=+5.2% | Growth Revenue=-0.9%
Additional Sources for CAG Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle